Aditxt regains Nasdaq minimum bid price compliance; hearing cancelled

Aditxt, Inc.

Received Nasdaq letter on April 8, 2025 confirming compliance with Listing Rule 5550(a)(2).
Scheduled April 22, 2025 hearing before Hearings Panel has been cancelled.
Common stock (ADTX) continues trading on Nasdaq Capital Market following compliance.
CEO Amro Albanna stated company is pleased to have regained compliance and remains focused on health innovations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.